Search results for “Selective inhibition” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 9,395 patents, we discovered top 449 key players by total patent application. Bristol Myers Squibb Co., Pharmacia Corp., Pfizer Inc. are dominant in this area. They take 10.56% of the total patent filing.
New York, United States
Patent: 425
New Jersey, United States
Patent: 292
New York, United States
Patent: 275
Connecticut, United States
Patent: 246
Hounslow, United Kingdom
Patent: 239
Basel-Stadt, Switzerland
Patent: 190
Pennsylvania, United States
Patent: 188
Switzerland
Patent: 182
Washington, United States
Patent: 178
Spain
Patent: 160
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 245 patents, we discovered top 25 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, GenFleet Therapeutics (Shanghai) Co., Ltd., HepaRegeniX GmbH are active in this area.
STARTUP
France
Patent: 78
STARTUP
Shanghai Shi, China
Patent: 43
STARTUP
Baden-Württemberg, Germany
Patent: 19
STARTUP
United States
Patent: 13
STARTUP
Essex, United Kingdom
Patent: 12
STARTUP
Spain
Patent: 12
STARTUP
Massachusetts, United States
Patent: 9
STARTUP
New York, United States
Patent: 8
STARTUP
California, United States
Patent: 7
STARTUP
Sweden
Patent: 7
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,956 patents applied in the last 5 years. We discover 495 most active companies in this area. The fast-growing Yuhan Corp., Prelude Therapeutics, Inc., Bristol Myers Squibb Co. take 9.92% of patent filing during this period.
South Korea
Patent: 77
Delaware, United States
Patent: 62
New York, United States
Patent: 55
STARTUP
Shanghai Shi, China
Patent: 43
Jiangsu Sheng, China
Patent: 37
Zhejiang Sheng, China
Patent: 37
Shanghai Shi, China
Patent: 35
Jiangsu Sheng, China
Patent: 30
Massachusetts, United States
Patent: 30
Massachusetts, United States
Patent: 29
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,956 patents in last 5 years, we discover 280 new entrants. GenFleet Therapeutics (Shanghai) Co., Ltd., Zhejiang Jinfang Pharmaceutical Co Ltd, Suzhou Zelgen Biopharmaceuticals Co., Ltd. are the most active new entrants in this area.
STARTUP
Shanghai Shi, China
Patent: 43
Zhejiang Sheng, China
Patent: 37
Jiangsu Sheng, China
Patent: 37
Shanghai Shi, China
Patent: 35
Massachusetts, United States
Patent: 30
Karnataka, India
Patent: 28
Lombardia, Italy
Patent: 21
South Korea
Patent: 20
Beijing Shi, China
Patent: 19
STARTUP
Baden-Württemberg, Germany
Patent: 19
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,910 patents, we discovered top 269 universities and scientific research institutions by total patent application. Simon Fraser University, Katholieke Universiteit Leuven, Emory University are dominant in this area. They take 11.73% of the total patent filing.
British Columbia, Canada
Patent: 46
Vlaams-Brabant, Belgium
Patent: 46
Georgia, United States
Patent: 35
Illinois, United States
Patent: 34
Jiangsu Sheng, China
Patent: 31
United States
Patent: 29
Tennessee, United States
Patent: 27
Colorado, United States
Patent: 27
California, United States
Patent: 25
Shanghai Shi, China
Patent: 25
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: